Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same
CA 2248630 A1 · Owner: Chorev, Michael · Inventors: Muhlrad, Andras; Chorev, Michael; Shteyer, Arie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to synthetic pseudopeptide derivatives of osteogenic growth polypeptide (OGP) and OGP (10-14) which may be linear or cyclic and , which are capable of enhancing bone cell proliferation and bone formation. Further, the present invention relates to pharmaceutical composition comprising as active ingredient at least one pseudopeptide derivative of the invention and to the use of these pseudopeptide derivatives in the preparation of a pharmaceutical composition for stimulating the formation of osteoblastic or fibroblastic cells, enhancing bone formation in osteopenic pathological conditions, repairing fractures, healing wounds grafting of intraosseous , implants, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 10, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 10, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 10, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.